| scholarly article | Q13442814 |
| P2093 | author name string | Wilson EM | |
| Sar M | |||
| French FS | |||
| Simental JA | |||
| Lane MV | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 510-518 | |
| P577 | publication date | 1991-01-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Transcriptional activation and nuclear targeting signals of the human androgen receptor | |
| P478 | volume | 266 |
| Q35998094 | A Recurrent Germline Mutation in the 5'UTR of the Androgen Receptor Causes Complete Androgen Insensitivity by Activating Aberrant uORF Translation |
| Q34550256 | A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland. |
| Q37900501 | A new trick of an old molecule: androgen receptor splice variants taking the stage?! |
| Q28116222 | A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth |
| Q37359901 | A novel missense mutation in the amino-terminal domain of the human androgen receptor gene in a family with partial androgen insensitivity syndrome causes reduced efficiency of protein translation |
| Q26747094 | A sting in the tail: the N-terminal domain of the androgen receptor as a drug target |
| Q30748653 | ARA67/PAT1 functions as a repressor to suppress androgen receptor transactivation |
| Q36681464 | Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation |
| Q38718942 | An Amyloidogenic Sequence at the N-Terminus of the Androgen Receptor Impacts Polyglutamine Aggregation. |
| Q36966859 | An androgen receptor N-terminal domain antagonist for treating prostate cancer. |
| Q37165574 | An imaging agent to detect androgen receptor and its active splice variants in prostate cancer |
| Q39499483 | Analysis of interdomain interactions of the androgen receptor |
| Q58789891 | Androgen Action in the Ovary |
| Q37636067 | Androgen Receptor (AR) Gene (CAG)n and (GGN)n Length Polymorphisms and Symptoms in Young Males With Long-Lasting Adverse Effects After Finasteride Use Against Androgenic Alopecia. |
| Q29036974 | Androgen Receptor Exon 1 Mutation Causes Androgen Insensitivity by Creating Phosphorylation Site and Inhibiting Melanoma Antigen-A11 Activation of NH2- and Carboxyl-terminal Interaction-dependent Transactivation |
| Q39227656 | Androgen Signaling in Prostate Cancer |
| Q40944089 | Androgen effects on the solubility and conformational change of the androgen receptor in baculovirus expression system |
| Q38946793 | Androgen receptor and miR-206 regulation in prostate cancer. |
| Q35611734 | Androgen receptor decoy molecules block the growth of prostate cancer |
| Q37050377 | Androgen receptor drives transcription of rat PACAP in gonadotrope cells |
| Q42738421 | Androgen receptor gene mutation, rearrangement, polymorphism. |
| Q37104443 | Androgen receptor gene mutations in human prostate cancer |
| Q35742116 | Androgen receptor in hepatocarcinogenesis: Recent developments and perspectives |
| Q36237251 | Androgen receptor regulation by histone methyltransferase Suppressor of variegation 3-9 homolog 2 and Melanoma antigen-A11. |
| Q35183663 | Androgen receptor signaling in prostate cancer development and progression |
| Q42573875 | Androgen receptor signalling in prostate cancer: the functional consequences of acetylation |
| Q92002903 | Androgen receptor signalling in the male adrenal facilitates X-zone regression, cell turnover and protects against adrenal degeneration during ageing |
| Q38865487 | Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic. |
| Q36063723 | Androgen receptor: structure, role in prostate cancer and drug discovery |
| Q36326556 | Androgen receptors, sex behavior, and aggression |
| Q55357541 | Androgen-Induced Immunosuppression. |
| Q57800002 | Androgen-dependent immune modulation in parasitic infection |
| Q33292178 | Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription |
| Q34049353 | Binding-folding induced regulation of AF1 transactivation domain of the glucocorticoid receptor by a cofactor that binds to its DNA binding domain |
| Q30500293 | Calmodulin protects androgen receptor from calpain-mediated breakdown in prostate cancer cells |
| Q36128635 | Cell Models for the Study of Sex Steroid Hormone Neurobiology. |
| Q36218806 | Cell-based assays for screening androgen receptor ligands |
| Q41083443 | Cell-specific inhibitory and stimulatory effects of Fos and Jun on transcription activation by nuclear receptors |
| Q34299330 | Characterization of androgen receptor structure and nucleocytoplasmic shuttling of the rice field eel. |
| Q42735199 | Characterization of karyopherins in androgen receptor intracellular trafficking in the yeast model |
| Q28543404 | Characterization of niphatenones that inhibit androgen receptor N-terminal domain |
| Q24653761 | Characterization of nuclear import of the domain-specific androgen receptor in association with the importin alpha/beta and Ran-guanosine 5'-triphosphate systems |
| Q35226136 | Codon reiteration and the evolution of proteins |
| Q33893810 | Complete testicular feminization caused by an amino-terminal truncation of the androgen receptor with downstream initiation |
| Q34775572 | Constitutive activity of the androgen receptor |
| Q24657742 | Convergence of two repressors through heterodimer formation of androgen receptor and testicular orphan receptor-4: a unique signaling pathway in the steroid receptor superfamily |
| Q39894032 | Cytoplasmic localization of the androgen receptor is independent of calreticulin |
| Q37183952 | Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy |
| Q35063026 | Delineation of a small region within the major transactivation domain of the human glucocorticoid receptor that mediates transactivation of gene expression |
| Q34558010 | Development of selective androgen receptor modulators (SARMs). |
| Q36290667 | Dexamethasone negatively regulates the activity of a chimeric dihydrofolate reductase/glucocorticoid receptor protein |
| Q43222841 | Dihydrotestosterone activates the MAPK pathway and modulates maximum isometric force through the EGF receptor in isolated intact mouse skeletal muscle fibres |
| Q34137546 | Dominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancer |
| Q24652929 | Epidermal-growth-factor-dependent phosphorylation and ubiquitinylation of MAGE-11 regulates its interaction with the androgen receptor |
| Q37482979 | Evolutionary history and functional characterization of androgen receptor genes in jawed vertebrates. |
| Q47825253 | Expression of steroidogenic enzymes and metabolism of steroids in COS-7 cells known as non-steroidogenic cells. |
| Q34172728 | Expression of the nuclear transport protein importin ß-1 and its association with the neurokinin 3 receptor in the rat hypothalamus following acute hyperosmotic challenge |
| Q34580343 | FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A. |
| Q29040033 | Gain in Transcriptional Activity by Primate-specific Coevolution of Melanoma Antigen-A11 and Its Interaction Site in Androgen Receptor |
| Q40958215 | Genes involved in testicular development and function |
| Q37206980 | Genetic Association Between Androgen Receptor Gene CAG Repeat Length Polymorphism and Male Infertility: A Meta-Analysis |
| Q47177866 | Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival |
| Q21284425 | Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor |
| Q33823680 | Hey1, a mediator of notch signaling, is an androgen receptor corepressor |
| Q39429490 | Hsp90 inhibitor 17-AAG inhibits progression of LuCaP35 xenograft prostate tumors to castration resistance. |
| Q40227114 | Human androgen receptor expressed in HeLa cells activates transcription in vitro |
| Q24329102 | Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription |
| Q35311828 | Identification of androgen receptor protein and 5alpha-reductase mRNA in human ocular tissues |
| Q38314229 | In vitro translation of androgen receptor cRNA results in an activated androgen receptor protein |
| Q37281115 | In vivo interaction of steroid receptor coactivator (SRC)-1 and the activation function-2 domain of the thyroid hormone receptor (TR) beta in TRbeta E457A knock-in and SRC-1 knockout mice |
| Q97883479 | Influence of Androgens on Immunity to Self and Foreign: Effects on Immunity and Cancer |
| Q47699658 | Inhibition of Androgen Receptor Function and Level in Castration-Resistant Prostate Cancer Cells by 2-[(isoxazol-4-ylmethyl)thio]-1-(4-phenylpiperazin-1-yl)ethanone. |
| Q24654156 | Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF |
| Q26853572 | Interferon-inducible p200-family protein IFI16, an innate immune sensor for cytosolic and nuclear double-stranded DNA: regulation of subcellular localization |
| Q33632245 | Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signaling |
| Q24633369 | Matricellular protein CCN1 activates a proinflammatory genetic program in murine macrophages |
| Q24556963 | Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction |
| Q35007914 | Melanoma antigen gene protein-A11 (MAGE-11) F-box links the androgen receptor NH2-terminal transactivation domain to p160 coactivators |
| Q34313140 | Melanoma antigen-A11 (MAGE-A11) enhances transcriptional activity by linking androgen receptor dimers |
| Q27646416 | Modulation of Androgen Receptor Activation Function 2 by Testosterone and Dihydrotestosterone |
| Q41205937 | Molecular determinants of sexual differentiation |
| Q40829556 | Molecular genetics of human androgen insensitivity |
| Q41886996 | Molecular processes leading to aberrant androgen receptor signaling and castration resistance in prostate cancer |
| Q41466777 | Muscle-bound? A tissue-selective nonsteroidal androgen receptor modulator |
| Q33595072 | Mutations of the androgen receptor gene identified in perineal hypospadias |
| Q36803788 | Natural disordered sequences in the amino terminal domain of nuclear receptors: lessons from the androgen and glucocorticoid receptors |
| Q38745981 | New insights into the androgen-targeted therapies and epigenetic therapies in prostate cancer. |
| Q41536310 | Nuclear import of the human androgen receptor |
| Q40394004 | Nuclear localization signals overlap DNA- or RNA-binding domains in nucleic acid-binding proteins |
| Q31081182 | PATHLOGIC-S: a scalable Boolean framework for modelling cellular signalling |
| Q27007098 | Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy |
| Q33623221 | Phenotypic variation and detection of carrier status in the partial androgen insensitivity syndrome |
| Q36139948 | Post-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor |
| Q37112738 | Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins |
| Q24298419 | Repression of androgen receptor activity by HEYL, a third member of the Hairy/Enhancer-of-split-related family of Notch effectors |
| Q64955772 | SIRT1 modulates aggregation and toxicity through deacetylation of the androgen receptor in cell models of SBMA. |
| Q30352713 | SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells. |
| Q24645579 | Selective androgen receptor modulators in preclinical and clinical development |
| Q97533909 | Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer |
| Q28081545 | Sex-based differences in skeletal muscle kinetics and fiber-type composition |
| Q90194958 | Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients? |
| Q30435809 | Simian virus 40 small t antigen mediates conformation-dependent transfer of protein phosphatase 2A onto the androgen receptor |
| Q37338900 | Sintokamide A Is a Novel Antagonist of Androgen Receptor That Uniquely Binds Activation Function-1 in Its Amino-terminal Domain. |
| Q36777961 | Site-specific androgen receptor serine phosphorylation linked to epidermal growth factor-dependent growth of castration-recurrent prostate cancer |
| Q28910351 | Ski-interacting protein (SKIP) interacts with androgen receptor in the nucleus and modulates androgen-dependent transcription. |
| Q24337882 | Small carboxyl-terminal domain phosphatase 2 attenuates androgen-dependent transcription |
| Q33810134 | Small molecule inhibitors targeting the "achilles' heel" of androgen receptor activity |
| Q38289592 | Specificity of simple hormone response elements in androgen regulated genes |
| Q40393976 | Splinkerettes--improved vectorettes for greater efficiency in PCR walking. |
| Q37576700 | Structural and functional relationships of the steroid hormone receptors' N-terminal transactivation domain |
| Q35417636 | Structural features discriminate androgen receptor N/C terminal and coactivator interactions |
| Q24537137 | Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations |
| Q36415787 | TM4SF3 and AR: A Nuclear Complex that Stabilizes Both Proteins |
| Q38114780 | Targeting alternative sites on the androgen receptor to treat castration-resistant prostate cancer |
| Q37496652 | Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer. |
| Q37301854 | Testosterone conversion blockade increases breathing stability in healthy men during NREM sleep |
| Q36915833 | Testosterone signaling through internalizable surface receptors in androgen receptor-free macrophages |
| Q24554379 | The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1 |
| Q34022799 | The N-terminal domain of the androgen receptor drives its nuclear localization in castration-resistant prostate cancer cells |
| Q24606948 | The androgen receptor gene mutations database |
| Q37074752 | The androgen receptor in hormone-refractory prostate cancer |
| Q34145721 | The association between androgen receptor gene CAG polymorphism and polycystic ovary syndrome: a case-control study and meta-analysis |
| Q35010014 | The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function |
| Q25257485 | The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells |
| Q24532004 | The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions |
| Q34771755 | Transcriptional repression of the alpha-subunit gene by androgen receptor occurs independently of DNA binding but requires the DNA-binding and ligand-binding domains of the receptor |
| Q33967239 | Transcriptional synergy between melanoma antigen gene protein-A11 (MAGE-11) and p300 in androgen receptor signaling |
| Q24616410 | Two mutations in the hormone binding domain of the vitamin D receptor cause tissue resistance to 1,25 dihydroxyvitamin D3 |
| Q33837335 | Two panels of steroid receptor luciferase reporter cell lines for compound profiling. |
| Q36454548 | Vav3 enhances androgen receptor splice variant activity and is critical for castration-resistant prostate cancer growth and survival |
| Q73121984 | c-Jun targets amino terminus of androgen receptor in regulating androgen-responsive transcription |
Search more.